A Trial of Anlotinib Combined With Docetaxel in EGFR Mutations Advanced Non Small Cell Lung Cancer Patients
Clinical trial NCT04619563 · UNKNOWN
Trial details
- NCT number
- NCT04619563
- Sponsor
- Shandong Cancer Hospital and Institute
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-04
- Primary completion
- 2021-10-01
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.